XPH icon

SPDR S&P Pharmaceuticals ETF

64 hedge funds and large institutions have $98.6M invested in SPDR S&P Pharmaceuticals ETF in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 7 closing their positions.

Holders
64
Holders Change
+6
Holders Change %
+10.34%
% of All Funds
1.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
14
Reduced
16
Closed
7
Calls
$250K
Puts
$1.54M
Net Calls
-$1.29M
Net Calls Change
-$58K
Name Market Value Shares Shares
Change
Shares
Change %
JPMorgan Chase & Co
51
JPMorgan Chase & Co
New York
$13.5K 339
Deutsche Bank
52
Deutsche Bank
Germany
$11.5K 290
CP
53
Castleview Partners
Texas
$9.62K 242
FMII
54
Farmers & Merchants Investments Inc
Nebraska
$8.67K 218
Carson Wealth (CWM LLC)
55
Carson Wealth (CWM LLC)
Nebraska
$8K 200
Barclays
56
Barclays
United Kingdom
$8K 200 +100 +100%
AA
57
Addison Advisors
Vermont
$7.47K 188
Qube Research & Technologies (QRT)
58
Qube Research & Technologies (QRT)
United Kingdom
$7.27K 183 +4 +2%
RIA
59
Realta Investment Advisors
Delaware
$5.04K 123 -100 -45%
AF
60
Arrow Financial
New York
$1.99K 50
FRA
61
Front Row Advisors
California
$1.8K 45
TFA
62
Transamerica Financial Advisors
Florida
$1K 1
NA
63
NewEdge Advisors
Louisiana
$398 10 +10 New
TRCT
64
Tower Research Capital (TRC)
New York
$238 6 +6 New
HNB
65
Huntington National Bank
Ohio
Envestnet Asset Management
66
Envestnet Asset Management
Illinois
-49,963 Closed
Jane Street
67
Jane Street
New York
-21,637 Closed
CI
68
CX Institutional
Indiana
-20,113 Closed
GSIAS
69
Garden State Investment Advisory Services
New Jersey
-15,617 Closed
Stifel Financial
70
Stifel Financial
Missouri
-6,159 Closed
CG
71
Cutler Group
California
-330 Closed
IA
72
IFP Advisors
Florida
-150 Closed
CFGS
73
Concourse Financial Group Securities
Alabama